research use only
Cat.No.S2599
|
In vitro |
DMSO
: 100 mg/mL
(128.72 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 776.87 | Formula | C15H11I4NO4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 51-48-9 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | NSC 36397 | Smiles | C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N | ||
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06096454 | Not yet recruiting | Hypothyroidism|Insulin Resistance |
Assiut University |
November 20 2023 | Phase 4 |
| NCT05918497 | Active not recruiting | Different Regimens in Treatment of Hypothyroidism During Fasting in Ramadan |
Sohag University |
April 25 2023 | -- |
| NCT05646420 | Completed | Autosomal Dominant Polycystic Kidney |
Mario Negri Institute for Pharmacological Research |
February 1 2023 | Not Applicable |
| NCT05412979 | Active not recruiting | Hypothyroidism |
Sention Therapeutics LLC |
April 29 2022 | Phase 2 |
| NCT06135948 | Completed | L-thyroxine |
Emirates Health Services (EHS)|University of Sharjah |
March 15 2022 | Phase 4 |
| NCT04712760 | Unknown status | Congenital Hypothyroidism |
Central Hospital Nancy France |
February 22 2021 | -- |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.